European Archives - Page 504 of 1102 - European Medical Journal

The Link Between Early Diet and Food Allergy

Allergy development is a complex process and depends on numerous factors, including postnatal influences, that guide the immune system…

Could the Sleep Hormone Melatonin Worsen Asthma?

Melatonin, the sleep hormone, potentiated the constriction of the airways, and consequently worsened asthma symptoms at night…

COVID-19: High-Flow Versus Low-Flow Oxygen Therapy

The effect of high-flow oxygen therapy versus conventional oxygen therapy in patients with severe COVID-19 has not been extensively studied

EADV 2021 Janssen-Sponsored Virtual Satellite Symposium: 'The Dermatologist’s Guide to the Clearance of the Skin'

A review of the Janssen-sponsored virtual satellite symposium titled: ‘The dermatologist’s guide to the clearance of the skin.’

Can Liver Cancer Immunotherapy Efficacy Be Improved Through Novel Approaches?

Sought to increase the efficacy of immunotherapy in patients with liver cancer by treatment in combination with adjuvant therapies…

The Cycle of Neurodegeneration in the Liver Associated with Fatty Liver Disease

Evidence has further shown a direct correlation between the severity of liver pathology and the level of nerve degeneration…

Janssen-Sponsored EADV 2021 Highlights

This Janssen-sponsored podcast explores highlights from EADV 2021. Hear from Professor Matthias Augustin and Professor Ulrich Mrowietz.

The Clinical and Therapeutic Implications of Meal Replacements: Sustained Weight Loss for Improved Liver Health and Diabetes Remission

Ard opened his talk by discussing the role of nutrition in T2DM. For some individuals, T2DM is a consequence of excess weight gain. The…

EMJ Diabetes 9 [Supplement 2] 2021

A symposium presented at the Obesity Week 2021 Virtual Meeting saw presentations from experts Jamy Ard, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA, and Wajahat Mehal, Yale University, New Haven, Connecticut, USA. Ard discussed the benefits of meal replacements, presenting data evidencing the associated increased rates of Type 2 diabetes mellitus remission.

A Shifting System

This week, Jonathan speaks with Bruce Gingles, Founder, Business, Entrepreneurship, Science & Technology (BEST).